Navigation Links
BioMarin to Present at the UBS Global Life Sciences Conference
Date:9/14/2010

NOVATO, Calif., Sept. 14 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Joshua Grass, Vice President, Corporate and Business Development of BioMarin, will present a company update at the UBS Global Life Sciences Conference in New York City on Tuesday, September 21, 2010 at 3:30 p.m. ET.  

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com.  A replay of the call will be archived on the site for one week following the call.

About BioMarinBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Other product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in clinical development for the treatment of MPS IVA and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

BioMarin®, Naglazyme® and Kuvan® are registered trademarks of BioMarin Pharmaceutical Inc.

Firdapse™ is a trademark of BioMarin Huxley Ltd.

Aldurazyme® is a registered trademark of BioMarin/Genzyme LLC.Contact:Eugenia ShenBioMarin Pharmaceutical Inc.(415) 506-6570
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioMarin to Present at the Stifel Nicolaus Healthcare Conference
2. BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease
3. BioMarin Acquires ZyStor Therapeutics, Inc.
4. BioMarin Initiates Phase 3b Study to Evaluate the Effects of Kuvan on Neurophychiatric Symptoms in Subjects with PKU
5. BioMarin to Acquire LEAD Therapeutics
6. BioMarin to Present at the Credit Suisse Healthcare Conference
7. BioMarin Announces Third Quarter 2009 Financial Results
8. BioMarin to Present at the Oppenheimer Healthcare Conference
9. BioMarin Acquires Huxley Pharmaceuticals, Inc.
10. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
11. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... -- ImmersiveTouch Inc., the global leader in virtual and ... strengthening their Executive Management team.  The Company ... Officer, Jay Banerjee as Chief Operating Officer, ... and Jia Luo , PhD as Vice President ... Bowman has 20 years experience commercializing innovative medical technologies. ...
(Date:1/13/2017)... Stock-Callers is currently reviewing the following ... WMGI ), Varian Medical Systems Inc. (NYSE: ... ), and NuVasive Inc. (NASDAQ: NUVA ). These ... a negative finish on Thursday, January 12 th , 2017, ... shares of health care companies in the S&P 500 were ...
(Date:1/13/2017)... 13, 2017 Wichita Laser Clinic ... treatments to Wichita, Kansas featuring ... treatments for skin rejuvenation, getting rid of unwanted tattoos, ... vascular lesions. "Since being in the aesthetics ... Wichita for laser tattoo removal and ...
Breaking Medicine Technology:
(Date:1/15/2017)... ... , ... "On Tour is a music themed slideshow production package which allows ... - CEO of Pixel Film Studios. , On Tour’s new slide presets come ... of their slideshows. Place each slide on top of another slide or piece of ...
(Date:1/15/2017)... ... January 15, 2017 , ... The ... is pleased to announce that it will be assisting HackensackUMC Mountainside with its ... Glen Ridge townships, servicing all surrounding towns. The firm will be working closely ...
(Date:1/14/2017)... California (PRWEB) , ... January 14, 2017 , ... "TransFreeze Volume 3 is a self ... freeze mask effect in Final Cut Pro X," said Christina Austin - CEO of Pixel ... create a unique freeze frame transition from one clip to the next. , ...
(Date:1/13/2017)... ... ... KOAMTAC ®, Inc., a leading manufacturer of Bluetooth barcode scanners and mobile ... collector at the National Retail Federation’s Big Show (NRF17) held January 15-17 in New ... need for more compact and rugged devices for collecting barcode data paired with a ...
(Date:1/13/2017)... Minneapolis, MN (PRWEB) , ... January 13, 2017 , ... ... have to endure jolts of pain whenever they brush their teeth. Sadly, most dental ... people who have sensitive gums and teeth. For these people, continuing their daily oral ...
Breaking Medicine News(10 mins):